FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 95 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2021. The put-call ratio across all filers is 2.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,589,000 | +810.3% | 280,183 | +214.2% | 0.00% | – |
| Q2 2022 | $614,000 | -26.0% | 89,181 | 0.0% | 0.00% | – |
| Q1 2022 | $830,000 | +14.8% | 89,181 | +75.3% | 0.00% | – |
| Q4 2021 | $723,000 | -86.4% | 50,863 | -76.1% | 0.00% | -100.0% |
| Q2 2021 | $5,303,000 | -48.8% | 213,044 | -42.4% | 0.00% | -50.0% |
| Q1 2021 | $10,359,000 | -80.2% | 369,640 | -75.3% | 0.00% | -80.0% |
| Q4 2020 | $52,218,000 | -42.3% | 1,496,246 | -18.8% | 0.01% | -47.4% |
| Q3 2020 | $90,536,000 | -8.0% | 1,842,611 | -15.3% | 0.02% | -13.6% |
| Q2 2020 | $98,441,000 | – | 2,175,113 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |